Convalescent plasma therapy for patients with severe COVID-19: A case series study

Coronavirus disease 2019 (COVID-19) is a novel acute respiratory infectious disease that can lead to multiple-organ dysfunction in patients with severe disease. However, there is a lack of effective antiviral drugs for COVID-19. Herein, we investigated the efficacy and safety of convalescent plasma...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jinbao, Weng, Heng, Lan, Changqing, Li, Hongyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351516/
https://www.ncbi.nlm.nih.gov/pubmed/35945787
http://dx.doi.org/10.1097/MD.0000000000029912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351516/
https://www.ncbi.nlm.nih.gov/pubmed/35945787
http://dx.doi.org/10.1097/MD.0000000000029912

Ejemplares similares